A new study in J Perinatology reports what happens to pregnancies affected by trisomy 13 (T13) or trisomy 18 (T18) when families are supported by a dedicated perinatal palliative care program from diagnosis through delivery. The researchers set out to evaluate outcomes not only for infants born with these chromosomal conditions, but also for pregnant patients who faced complex decisions about care intensity, comfort, and survival expectations.
T13 and T18 are rare genetic disorders associated with severe developmental impairment and high neonatal mortality. Because prognosis is poor and trajectories can be highly variable, clinicians and families often struggle to align medical interventions with goals centered on quality of life. The study focuses on a care model that integrates palliative specialists into perinatal planning rather than introducing them later in the clinical course.
In this center-based analysis, the team reviewed cases involving T13 or T18 managed under a structured perinatal palliative care pathway. The program emphasized anticipatory counseling, symptom-focused management, and coordinated decision-making among obstetrics, neonatology, genetics, and palliative care services.
Technically, the paper evaluates outcomes across the pregnancy-to-infant continuum, including how prenatal counseling influenced delivery planning and how newborn management reflected comfort-based objectives. Researchers also describe infant outcomes under palliative-oriented neonatal care, capturing the practical reality that many infants experience limited time, while others may survive longer than expected.
By examining a single program’s experience, the study sheds light on whether a dedicated palliative framework can standardize conversations and reduce uncertainty. The investigators argue that early involvement may help families understand likely clinical courses, including possibilities for non-invasive supportive care, time-limited interventions, and clear thresholds for escalation.
Importantly, the findings suggest that when palliative care is embedded in perinatal management, care plans can be implemented consistently with documented family goals. This approach can support shared decision-making while maintaining medical readiness in case of complications.
The analysis also highlights that outcomes must be interpreted in context: disease severity, gestational factors, and parental preferences all shape what “success” means for each family. Still, the reported experience provides a concrete benchmark for other hospitals seeking to build similar pathways.
Overall, the study presents viral-science news for clinical teams: a perinatal palliative care program appears capable of coordinating complex genetic cases with a focus on comfort, transparency, and aligned care decisions for both patients and infants.
Subject of Research: Outcomes of pregnancies and infants affected by trisomy 13 and trisomy 18 in a center with perinatal palliative care.
Article Title: Outcomes of patients with trisomy 13 and 18 in a center with a dedicated perinatal palliative care program.
Article References: Brady, S., McNamee-Tweed, B., Zhang, Y.S. et al. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02821-8
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41372-026-02821-8
Tags: decision-making in trisomy 13 and 18 pregnanciesfamily-centered care planning for chromosomal abnormalitiesimpactintegrated palliative care models in perinatal medicineneonatal mortality in T13 and T18obstetric and neonatal management of trisomy 13 and 18perinatal palliative care for chromosomal disordersprenatal counseling for severe genetic conditionsquality of life considerations in perinatal geneticssymptom-focused neonatal care strategiestrisomy 13 and 18 pregnancy outcomes
